Effects of Yishenjiangzhuo granules on immunity and bone metabolism in patients with stage 3-4 chronic kidney disease

被引:0
|
作者
Jing Zheng [1 ]
Yingda Lin [2 ]
Lu Huang [3 ]
Caifeng Chen [3 ]
Xuemin Zheng [3 ]
Xinhong Wu [3 ]
Ciyun Liu [3 ]
机构
[1] Nephropathy Department, Fujian Provincial People's Hospital
[2] Teaching and Research Section of Internal Medicine, Fujian Provincial People's Hospital
[3] Postgraduate Department, Integration of Traditonal Chinese and Western Medicine, Fujian University of Traditional Chinese Medicine
关键词
B lymphocytes; T-lymphocytes; regulatory; Osteocalcin; Acid phosphatase; Yishenjiangzhuo granules;
D O I
暂无
中图分类号
R692 [肾疾病];
学科分类号
摘要
OBJECTIVE:To determine the effects of Yishenjiangzhuo granules(YJG)on bone metabolism and to explore the changes in levels of bone Gla protein(BGP),tartrate-resistant acid phosphatase(TRAP),as well as their relationships with levels of B cells,regulatory T cells(Treg)and interleukin(IL)-17 in patients with stage 3-4 chronic kidney disease(CKD)before and after treatment.METHODS:Fifty-three stage 3-4 CKD patients were divided randomly into two groups:YJG treatment and control.Peripheral blood was taken from two groups of CKD patients and 21 healthy subjects in the normal group.The parameters determined were the levels of CD4+,CD19+,CD19+CD69+,CD19+AV,Treg(CD4+CD25+CD127lo),BGP,TRAP,IL-17,calcium,phosphate,blood urea nitrogen,serum creatinine(SCr),hemoglobin(Hb)in peripheral blood,and urinary creatinine.Calcium-phosphate products and endogenous creatinine clearance rate(CCr)were calculated according to standard protocols.RESULTS:In YJG and control groups,SCr levels were lowered(P<0.01)after treatment,whereas CCr(P<0.05)as well as Hb and albumin levels(P<0.01)were increased.The changes in levels of CCr and SCr in the YJG group were more significant.After treatment,CD19+CD69+and Treg levels in the two groups varied(P<0.01)compared with those of the normal group;the level of CD19+increased but the levels of CD4+and CD19+AV decreased(P<0.01)in both groups.Compared with the control group,the changes of CD19+and CD19+AV in the YJG group were more apparent(P<0.05).Compared with the normal group,levels of IL-17 in both groups increased significantly(P<0.01),and the difference in the control group was more significant(P<0.05).After treatment,the TRAP level increased(P<0.05),but the difference in BGP level(P>0.05)was not significant.CONCLUSION:In stage 3-4 CKD patients,B cells and IL-17 participated in the induction of osteoclast activation.YJG could also elevate the level of B cells and decrease their apoptosis,but showed no significant effects on active B cells,IL-17 or osteoclast activity.
引用
收藏
页码:620 / 625
页数:6
相关论文
共 50 条
  • [1] Effects of Yishenjiangzhuo granules on immunity and bone metabolism in patients with stage 3-4 chronic kidney disease
    Zheng, Jing
    Lin, Yingda
    Huang, Lu
    Chen, Caifeng
    Zheng, Xuemin
    Wu, Xinhong
    Liu, Ciyun
    JOURNAL OF TRADITIONAL CHINESE MEDICINE, 2013, 33 (05) : 620 - 625
  • [2] Paricalcitol does not improve glucose metabolism in patients with stage 3-4 chronic kidney disease
    de Boer, Ian H.
    Sachs, Michael
    Hoofnagle, Andrew N.
    Utzschneider, Kristina M.
    Kahn, Steven E.
    Kestenbaum, Bryan
    Himmelfarb, Jonathan
    KIDNEY INTERNATIONAL, 2013, 83 (02) : 323 - 330
  • [3] Cinacalcet HCl Treatment in Patients with Chronic Kidney Disease Stage 3-4
    Tominaga, Yoshihiro
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2009, 1 : 1465 - 1466
  • [4] EFFECT OF BONE METABOLISM PROTOCOL ON STAGE 4 CHRONIC KIDNEY DISEASE PATIENTS
    Mali, Padmavathi
    Kankanala, Sucharitha
    Henner, David
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2011, 57 (04) : A62 - A62
  • [5] SAFETY AND TOLERABILITY OF ROSIGLITAZONE IN STAGE 3-4 CHRONIC KIDNEY DISEASE
    Chan, D.
    Watts, G.
    Irish, A.
    Dogra, G.
    NEPHROLOGY, 2008, 13 : A132 - A132
  • [6] The pregnancy outcomes in patients with stage 3-4 chronic kidney disease and the effects of pregnancy in the long-term kidney function
    He, Yingdong
    Liu, Jing
    Cai, Qingqing
    Lv, Jicheng
    Yu, Feng
    Chen, Qian
    Zhao, Minghui
    JOURNAL OF NEPHROLOGY, 2018, 31 (06) : 953 - 960
  • [7] Effect of serum albumin on the prognosis of elderly patients with stage 3-4 chronic kidney disease
    Fan, Hongru
    Yang, Jihong
    Liu, Lili
    Qiao, Yu
    Wang, Meng
    Qiu, Lei
    Shi, Hong
    Xi, Huan
    Wang, Yao
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2017, 49 (05) : 859 - 865
  • [8] FAVORABLE EFFECT OF LEVOTHYROXINE ON NUTRITIONAL STATUS OF PATIENTS WITH STAGE 3-4 CHRONIC KIDNEY DISEASE
    Tang, W.
    Chen, Q.
    Chen, L.
    Chen, S.
    Shao, X.
    Wang, X.
    ACTA ENDOCRINOLOGICA-BUCHAREST, 2018, 14 (03) : 338 - 345
  • [9] Causal Factors of Anaemia in Kidney Transplant (KT) Patients with Stage 3-4 Chronic Kidney Disease (CKD).
    Gentil, Miguel A.
    Cabello, V.
    Campistol, J. M.
    Gomez, C.
    Polo, J.
    Ortega, F.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 247 - 248
  • [10] Effects of oral activated charcoal on hyperphosphatemia and vascular calcification in Chinese patients with stage 3-4 chronic kidney disease
    Gao, Ying
    Wang, Guiyun
    Li, Yang
    Lv, Chenxiao
    Wang, Zunsong
    JOURNAL OF NEPHROLOGY, 2019, 32 (02) : 265 - 272